Impact of Hypoglycemia on Health-Related Quality of Life among Type 2 Diabetes: A Cross-Sectional Study in Thailand
Table 1
Patient demographics by occurrence of hypoglycemia in previous 6 months.
Variables
No hypoglycemia ()
Hypoglycemia ()
value
Male, (%)
228 (50.8)
93 (46.0)
0.272a
Age (years)
66.20 (9.59)
63.94 (10.65)
0.008b†
Duration of DM (years), median (IQR)
10 (5, 15)
10 (6, 15)
0.531c
Height (cms)
160.5 (8.4)
160.3 (9.3)
0.746b
Body weight (kgs)
66.5 (12.9)
65.2 (14.5)
0.134b
Did not take physical regular activity, (%)
156 (34.3)
86 (42.8)
0.038a†
Alcohol consumption, (%)
Never
318 (69.6)
149 (74.5)
0.030a†
Occasionally
116 (25.4)
45 (22.5)
Daily
1 (0.2)
3 (1.5)
Unknown
22 (4.8)
3 (1.5)
Low-sugar diet, (%)
214 (47.6)
116 (57.7)
0.018a†
Weight change in previous 12 months
No change
87 (19.3)
42 (21.1)
0.798a,β
Gained
158 (35.0)
65 (32.7)
Lost
192 (42.5)
85 (42.7)
Unknown
15 (3.3)
7 (3.5)
Waist circumference (cm)
92.4 (10.1)
91.0 (11.7)
0.119b
SBP (mmHg)
135.7 (17.1)
133.5 (17.6)
0.128b
DBP (mmHg)
74.5 (10.2)
73.4 (9.8)
0.186b
Hypoglycemic agents, (%)
Sulfonylurea (SU)
93 (20.3)
45 (22.3)
0.604a
Combination of SU and metformin
364 (79.7)
157 (77.7)
Macro- and/or microvascular complications, (%)
99 (21.7)
38 (18.8)
0.407a
aChi-squared test or Fisher exact test as appropriate; bindependent sample -test; cMann-Whitney test. † indicates statistically significant difference between the occurrence of hypoglycemia groups ( value < 0.05). βOnly known data used for analysis. Data are the unless otherwise specified. Abbreviation: SD: standard deviation; IQR: interquartile range.